Inflammatory components of human tear fluid

Australian and New Zealand Journal of Ophthalmology

Volumn 24, Issue 2 SUPPL., 1996, Pages 13-16

  Thakur, Archana ^a   Willcox, Mark D P ^a   Morris, Carol Ann ^a   Holden, Brien A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; PLASMIN;

CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; HUMAN; KERATITIS; SOFT CONTACT LENS; TEAR FILM;

EID: 0029794749     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1996.tb00983.x     Document Type: Conference Paper

References (19)

1. Leopold IH, Gaster RN. Ocular inflammation and anti-inflammatory drugs. In: Kaufmann HE, Baron BA, McDonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone, 1988;67-84.
2. Foster CS. Basic ocular immunology. In: Kaufmann HE, Baron BA, McDonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone, 1988;85-122.
3. Samolin G. Cellular response to inflammation at the limbus. Eye 1989;3:167-73.
4. Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Opthalmol Vis Sci 1989;33:626-40.
5. Mondino BJ, Ratajczak HV, Goldberg DB, Schanzlin DJ, Brown SI. Alternative and classical pathway components of complement in the normal cornea. Arch Opthalmol 1980;98:2041-4.
6. Monlido BJ, Zaidman GW. Hemolytic complement in tears. Ophthalmic Res 1983;15:208-16.
7. Yamamoto GK, Allansmith MR. Complements in tears of normal humans. Am J Opthalmol 1979;88:758-63.
8. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HI. Differential expression of the complement regulatory proteins in human eye. Invest Opthalmol Vis Sci 1993;34:3579-84.
9. Lass JH, Walter El, Bums TE, Grossiklaus HE, Roat MI, Skelnic DL, et al. Expression of two molecular forms of complement decay-accelerating factors in the eye and lacrimal gland. Invest Opthalmol Vis Sci 1990;31:1136-48.
10. Chan KY. Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound closure. Exp Eye Res 1986;42:417-31.
11. Berman MB, Manseau E, Law M, Aiken D. Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface. Invest Opthalmol Vis Sci 1983;24:1358-66.
12. Fujikawa LS, Foster CS, Harrist TH. Fibronectin in rabbit corneal wounds. Lab Invest 1981;45:120-9.
13. Berman M, Kanyon K, Khayashi K, L'Hernault N. The pathogenesis of epithelial defects and stromal ulceration. In: Cavanagh D. The cornea. Trans Wld Congr The Cornea III. NewYork: Raven Press, 1988;35-43.
14. Ward PA. A plasmin split fragment of C3 as a new chemotactic factor. J Exp Med 1967;126:189-206.
15. Rother K, Till GO, eds. The complement system. New York: Springer-Verlag, 1988.
16. Willcox MDP, Patrikakis M, Knox KW. Degradative enzymes of oral streptococci. Aust Dent J 1995;40:121-8.
17. Faried HF, Tachibana T, Okuda T. The secretion of the third component of the complement (C3) by human polymorphonuclear leukocytes from both normal and systemic lupus erythamatous cases. Scand J Immunol 1993;37:19-28.
18. Vannas A, Sweeney DF, Holden BA, Sapyska E, Salonen EM, Vaheri A. Tear plasmin activity with contact lens wear. Curr Eye Res 1992;11:243-51.
19. Holden BA, La Hood D, Grant T, Newton-Howes J, Baleriola-Lucas C, Willcox MDP, Sweeney DF.The role of gram-negative bacteria in inducing contact lens related acute red eye (CLARE) responses. CLAO J 1996;22: (in press).